Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations
Top Cited Papers
- 1 December 2007
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 6 (12), 1094-1105
- https://doi.org/10.1016/s1474-4422(07)70290-9
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- FDA draft guidance and health-outcomes researchThe Lancet, 2007
- TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trialThe Lancet Neurology, 2006
- NXY-059 for Acute Ischemic StrokeThe New England Journal of Medicine, 2006
- How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scalesJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trialBMJ, 2005
- Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trialThe Lancet, 2003
- Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease ProgressionJAMA, 2003
- Neuroprotection in Parkinson's disease: Clinical trialsAnnals of Neurology, 2003
- DATATOP: A Multicenter Controlled Clinical Trial in Early Parkinson's DiseaseArchives of Neurology, 1989
- Rating neurologic impairment in multiple sclerosisNeurology, 1983